0 CHECKOUT

Global Immunology Partnering 2010-2016: Deal trends, players and financials

  • ID: 2229059
  • July 2016
  • Region: Global
  • 1000 Pages
  • CurrentPartnering
1 of 4

Global Immunology Partnering 2010 to 2016 provides the full collection of Immunology disease deals signed between the world’s pharmaceutical and biotechnology companies since 2010.

Trends in Immunology partnering deals
Financial deal terms for headline, upfront and royalty by stage of development
Immunology partnering agreement structure
Immunology partnering contract documents
Top Immunology deals by value
Most active Immunology dealmakers

Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor’s product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.

The report takes readers through the comprehensive Immunology disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Immunology deals.

The report presents financial deal terms values for Immunology deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers READ MORE >

Note: Product cover images may vary from those shown
2 of 4

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in Immunology dealmaking

2.1. Introduction
2.2. Immunology partnering over the years
2.3. Immunology partnering by deal type
2.4. Immunology partnering by industry sector
2.5. Immunology partnering by stage of development
2.6. Immunology partnering by technology type
2.7. Immunology partnering by therapeutic indication

Chapter 3 -Financial deal terms for Immunology partnering

3.1. Introduction
3.2. Disclosed financials terms for Immunology partnering
3.3. Immunology partnering headline values
3.4. Immunology deal upfront payments
3.5. Immunology deal milestone payments
3.6. Immunology royalty rates

Chapter 4 - Leading Immunology deals and dealmakers

4.1. Introduction
4.2. Most active in Immunology partnering
4.3. List of most active dealmakers in Immunology
4.4. Top Immunology deals by value

Chapter 5 - Immunology contract document directory

5.1. Introduction
5.2. Immunology partnering deals where contract document available

Chapter 6 - Immunology dealmaking by therapeutic target

6.1. Introduction
6.2. Deals by Immunology therapeutic target

Appendices

Appendix 1 - Directory of Immunology deals by company A-Z 2010 to 2016
Appendix 2 - Directory of Immunology deals by deal type 2010 to 2016
Appendix 3 - Directory of Immunology deals by stage of development 2010 to 2016
Appendix 4 - Directory of Immunology deals by technology type 2010 to 2016
Further reading on dealmaking
Deal type definitions

Current Partnering
Current Agreements
Recent report titles from CurrentPartnering

Table of figures

Figure 1: Immunology partnering since 2010
Figure 2: Immunology partnering by deal type since 2010
Figure 3: Immunology partnering by industry sector since 2010
Figure 4: Immunology partnering by stage of development since 2010
Figure 5: Immunology partnering by technology type since 2010
Figure 6: Immunology partnering by indication since 2010
Figure 7: Immunology deals with a headline value
Figure 8: Immunology deals with upfront payment values
Figure 9: Immunology deals with milestone payment
Figure 10: Immunology deals with royalty rates
Figure 11: Active Immunology dealmaking activity- 2010 to 2016
Figure 12: Top Immunology deals by value since 2010

Note: Product cover images may vary from those shown
3 of 4

Global Immunology Partnering 2010 to 2016 provides the reader with the following key benefits:

In-depth understanding of Immunology deal trends since 2010
Access Immunology deal headline, upfront, milestone and royalty data
Research hundreds of actual contracts between Immunology partner companies
Comprehensive access to over 750 links to actual Immunology deals entered into by the world’s biopharma companies
Indepth review of Immunology deals entered into by the top 25 most active dealmakers
Benchmark the key deal terms companies have agreed in previous deals
Identify key terms under which companies partner Immunology opportunities
Uncover companies actively partnering Immunology opportunities

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

PURCHASING OPTIONS

HAVE A QUESTION?

EMAIL US VIEW FAQs

RELATED PRODUCTS from Db

Our Clients

  • Amgen Inc.
  • Bayer AG
  • Bio-Rad Laboratories, Inc.
  • Beckman Coulter, Inc.
  • Novartis AG
  • Baxter International Inc.